Human papillomavirus is the most common sexually transmitted infection in the U.S. according to the Centers for Disease Control and Prevention. That fact alone makes the work of James Bashkin, a professor of chemistry at ...
Nov 17, 2015
0
19
Researchers from Aarhus University and Aarhus University Hospital have - in collaboration with international researchers - found a cause for why contracting herpes virus ends up being fatal for some people. While most people ...
Oct 20, 2015
4
26
Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the ...
Oct 9, 2015
0
19
Early treatment of flu-hospitalized people 65 and older with flu antiviral medications cuts the duration of their hospital stay and reduces their risk of needing extended care after discharge, a new CDC study finds. The study ...
Sep 7, 2015
0
17
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus's entry into cells and halt the disease in its tracks, according to researchers at the University of ...
Aug 7, 2015
0
77
A Canadian research team at the IRCM in Montreal, led by molecular virologist Eric A. Cohen, PhD, made a significant discovery on how HIV escapes the body's antiviral responses. The team uncovered how an HIV viral protein ...
Jul 15, 2015
0
39
Scientists behind the first global distribution maps of two species of dengue and chikungunya-carrying mosquitoes warn they are spreading to new areas where they could cause disease.
Jun 30, 2015
0
28
Over 35 million people worldwide are currently infected by HIV. Antiviral therapies can keep the virus from multiplying. However, no drug can cure infection so far, because various cell types continue to carry the virus in ...
Jun 18, 2015
0
12
The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the ...
Jun 1, 2015
0
12
New data from an ongoing Phase III trial revealed today at The International Liver Congress 2015 show that the use of hepatitis C immune globulin (HCIG, Civacir) can effectively prevent hepatitis C virus (HCV) recurrence ...
Apr 23, 2015
0
4
